logo

Galmed Pharmaceuticals Ltd. (GLMD)



Trade GLMD now with
  Date
  Headline
8/2/2018 7:17:17 AM Galmed Pharma Q2 Loss Per Share $0.17 Vs Loss $0.22 Last Year
6/19/2018 9:49:47 PM Galmed Pharma Prices Underwritten Public Offering Of 5 Mln Shares At $15.00/shr
6/18/2018 6:32:51 AM Galmed Pharma Intends To Offer Public Offering To Raise Aggregate Proceeds Of About $75 Mln
5/9/2018 7:15:27 AM Galmed Pharma Q1 Net Loss $2.5 Mln Or $0.17/Shr Vs Loss Of $3.2 Mln Or $0.26/Shr Last Year
4/3/2018 7:11:10 AM Galmed Reports Pricing Of $6.0 Mln Registered Direct Offering
3/13/2018 7:10:55 AM Galmed Q4 Net Loss $3.6 Mln Or $0.27 Per Share
10/5/2017 8:08:28 AM Galmed Pharma Announces Publication Of Data On Aramchol Mechanism Of Action In Hepatology Communications
7/31/2017 6:12:42 AM Galmed Pharma Q2 Net Loss $2.7 Mln Or $0.22/shr Vs Loss Of $4.3 Mln Or $0.39/Shr Last Year
5/15/2017 8:07:09 AM Galmed Pharma Q1 Net Loss $3.2 Mln Or $0.26/shr Vs. Net Loss $4.0 Mln Or $0.36/shr Last Year
5/3/2017 8:33:22 AM Therapix Biosciences Says Appoints Josh Blacher As CFO, Effective Immediately
3/23/2017 7:36:35 AM Galmed Pharma Q4 Net Loss $4.8 Mln Or $0.40/Shr Vs $3.2 Mln Or $0.29/Shr Last Year